17 extractive question-and-answer pairs built from Tuberculosis | Our World in Data, published by ourworldindata.org. Every answer is a verbatim span of text the source prints, and each row carries the passage it sits in, its offset in that passage, the source quote, the page and the location in the document, so any row can be checked against the original. 12 of the 17 pairs (70.6%) are explanatory questions and 5 restate a figure. 94.12% of rows pass the corpus quality gate.
Use the API URL with your free DD token in notebooks, scripts, and pipelines.
https://www.desidata.in/api/datasets/tuberculosis-question-and-answer-dataset/downloadDataset downloads are free. For Python or API downloads, sign in once and create a free DD token; set it as DD_TOKEN or save it in your notebook's secrets. Requests are linked to your account so your download history and counts stay accurate.
# One-time install: pip install desidata
# Set DD_TOKEN in your environment first (create a free token in Profile & settings).
import desidata
df = desidata.load("tuberculosis-question-and-answer-dataset")
df.head()Sign in with Google to download.
Usable for analysis, but expect some cleaning before you rely on it.
Annual Report 2015-16 by agriwelfare.gov.in - Question and Answer Dataset
Economy · 1,013 rows
Higher Education in India - Question and Answer Dataset
Economy · 1,594 rows
Gender Policy of NABARD - Question and Answer Dataset
Economy · 14 rows
ICAR Annual Report 2025-26 - Question and Answer Dataset
Economy · 1,101 rows
First 10 of 17 rows
| question | answer | context | answer_start | question_type | knowledge_quality_score | source_quote | source_page | source_location | confidence | validation_status |
|---|---|---|---|---|---|---|---|---|---|---|
| What does 'treatment success rate' mean in the context of tuberculosis? | those who have been cured or have completed the whole course of treatment | Without proper treatment, the bacteria can survive and potentially develop antibiotic resistance. This drug-resistant bacteria can then spread to others, causing infections that are much more difficult and expensive to treat, and their treatments can have more side effects. The chart shows the “treatment success rate” among people with tuberculosis – those who have been cured or have completed the whole course of treatment. This is compared between all new cases of tuberculosis versus those withdrug-resistant tuberculosis. You can see that drug-resistant tuberculosis, especiallyexcessively drug-resistant tuberculosis, has a lower treatment success rate. | 353 | definition | 1.000 | The chart shows the “treatment success rate” among people with tuberculosis – those who have been cured or have completed the whole course of treatment. | p[31] | 0.700 | valid | |
| What causes tuberculosis? | caused by the bacteriaMycobacterium tuberculosis | In richer countries, the impact of tuberculosis has been reduced significantly over history, but in poorer parts of our world, it continues to be a major challenge even today: it causes an estimated1.2 million deathsannually. Tuberculosis is caused by the bacteriaMycobacterium tuberculosis. The bacteria spreads through respiratory particles and tends to cause tuberculosis in people with risk factors such asundernourishment,HIV/AIDS,smoking, and existing chronic conditions. | 242 | definition | 0.980 | Tuberculosis is caused by the bacteriaMycobacterium tuberculosis. | p[0] | 0.850 | valid | |
| What is AnHIVinfection? | a majorrisk factorfor developing tuberculosis | In recent years, there has been some improvement in the treatment success rate of people with drug-resistant tuberculosis – with better testing, new guidelines on using antibiotic treatment appropriately, and new drugs – but there is still more progress that can be achieved.9 AnHIVinfection is a majorrisk factorfor developing tuberculosis.10 The map shows the estimated share of tuberculosis patients who also have HIV. | 295 | definition | 0.980 | AnHIVinfection is a majorrisk factorfor developing tuberculosis. | p[31] | 0.850 | valid | |
| What advancements have helped reduce the impact of tuberculosis in wealthy countries? | the development of antibiotics and improvements in healthcare and living standards | This leaves them vulnerable, and also increases the risk thatantibiotic-resistant strainsof the bacteria will develop, which are much more difficult and expensive to treat. With greater effort to tackle its risk factors and improve testing and treatment for the disease, the world can relegate tuberculosis to history — not just in the richer parts of the world, but for everyone. On this page, you will find global data and trends on tuberculosis, including testing, treatment, and vaccination. In high-income countries, tuberculosis is largely a disease of the past. Since the beginning of the 20th century, its impact has been significantly reduced with the development of antibiotics and improvements in healthcare and living standards. But in poorer regions of the world, it is still very common. This makes it one of the most commoncauses of deathfrom infectious diseases, globally. | 657 | relationship | 0.970 | Since the beginning of the 20th century, its impact has been significantly reduced with the development of antibiotics and improvements in healthcare and living standards. | p[0] | |||
| What makes tuberculosis one of the most common causes of death from infectious diseases globally? | it is still very common | This leaves them vulnerable, and also increases the risk thatantibiotic-resistant strainsof the bacteria will develop, which are much more difficult and expensive to treat. With greater effort to tackle its risk factors and improve testing and treatment for the disease, the world can relegate tuberculosis to history — not just in the richer parts of the world, but for everyone. On this page, you will find global data and trends on tuberculosis, including testing, treatment, and vaccination. In high-income countries, tuberculosis is largely a disease of the past. Since the beginning of the 20th century, its impact has been significantly reduced with the development of antibiotics and improvements in healthcare and living standards. But in poorer regions of the world, it is still very common. This makes it one of the most commoncauses of deathfrom infectious diseases, globally. | 777 | relationship | 0.970 | But in poorer regions of the world, it is still very common. | p[0] | 0.700 | valid | |
| What risks are associated with lower rates of tuberculosis diagnosis? | serious health complications, including the risk of dying from the disease | These symptoms are not specific to tuberculosis, so a medical diagnosis is crucial. This may involveskin tests, chest X-rays, blood tests, sputum (spit) tests, or bacterial DNA tests. the level of testing to diagnose tuberculosis is inadequate in many countries, which means many cases go unnoticed. The map shows estimates of the share of people with tuberculosis who are diagnosed. As you can see, case detection rates tend to be lower in countries in Africa and Asia. Lower rates of diagnosis put people at risk of serious health complications, including the risk of dying from the disease. It also increases the risk thatdrug-resistant tuberculosiswill develop. People with tuberculosis require treatment with a specific combination of antibiotic medications that can kill the bacteria. | 518 | relationship | 0.970 | Lower rates of diagnosis put people at risk of serious health complications, including the risk of dying from the disease. | p[15] | 0.700 | valid | |
| What can happen if tuberculosis bacteria are not treated effectively? | the bacteria can survive and potentially develop antibiotic resistance | Without proper treatment, the bacteria can survive and potentially develop antibiotic resistance. This drug-resistant bacteria can then spread to others, causing infections that are much more difficult and expensive to treat, and their treatments can have more side effects. The chart shows the “treatment success rate” among people with tuberculosis – those who have been cured or have completed the whole course of treatment. This is compared between all new cases of tuberculosis versus those withdrug-resistant tuberculosis. You can see that drug-resistant tuberculosis, especiallyexcessively drug-resistant tuberculosis, has a lower treatment success rate. | 26 | relationship | 0.970 | Without proper treatment, the bacteria can survive and potentially develop antibiotic resistance. | p[31] | 0.700 | valid | |
| What are the effects of the spread of drug-resistant bacteria? | causing infections that are much more difficult and expensive to treat, and their treatments can have more side effects | Without proper treatment, the bacteria can survive and potentially develop antibiotic resistance. This drug-resistant bacteria can then spread to others, causing infections that are much more difficult and expensive to treat, and their treatments can have more side effects. The chart shows the “treatment success rate” among people with tuberculosis – those who have been cured or have completed the whole course of treatment. This is compared between all new cases of tuberculosis versus those withdrug-resistant tuberculosis. You can see that drug-resistant tuberculosis, especiallyexcessively drug-resistant tuberculosis, has a lower treatment success rate. | 154 | relationship | 0.970 | This drug-resistant bacteria can then spread to others, causing infections that are much more difficult and expensive to treat, and their treatments can have more side effects. | p[31] | 0.700 | valid | |
| What non-respiratory symptoms can occur in people infected with tuberculosis? | weight loss, breathlessness, fever, or night sweats | The chart shows that most of those who die from tuberculosis are adults. Its mortality in adults is due to a range of risk factors that make some people more vulnerable to tuberculosis. These includesmoking, certain occupations such as nursing and healthcare work,HIV/AIDS, and chronic health conditions. In the early 1990s, tuberculosis used to kill around 250,000 children annually. But child deaths from the disease have shrunk as BCG vaccines have become morewidely used. Although the world has had a childhood vaccine against tuberculosis for over a hundred years, a vaccine for adults is still unavailable. Although tuberculosis is typically a disease of the lungs, the bacteria can affect many organs in the body, and people who are infected don’t always have respiratory symptoms. Instead, they may experience weight loss, breathlessness, fever, or night sweats. | 818 | list | 0.820 | Instead, they may experience weight loss, breathlessness, fever, or night sweats. | p[15] | 0.700 | valid | |
| What types of illnesses are individuals with HIV/AIDS at risk of contracting? | multiple diseases which can be fatal, including tuberculosis | HIV/AIDSmakes people vulnerable to multiple diseases which can be fatal, including tuberculosis. Typically, in international statistics, “tuberculosis deaths” refers to deaths in HIV-negative people, while tuberculosis deaths among people with HIV are classified under “HIV/AIDS related deaths”. Here, the composition of HIV/AIDS related deaths are broken down to better understand the impact of tuberculosis among people with HIV/AIDS. The BCG vaccine’s efficacy varies between locations and is generally found to be more effective in countries far from the equator. This is likely due to a range of factors, such as different strains ofMycobacterium tuberculosisaround the world; exposure to other mycobacteria in the environment, which can affect the immune system’s response to the vaccine; and other factors. | 35 | list | 0.820 | HIV/AIDSmakes people vulnerable to multiple diseases which can be fatal, including tuberculosis. | p[80] | 0.700 | valid |
Read straight from the file — download or use the API URL for the full dataset.
| 0.700 |
| valid |